Weeratunga; Gamini

Patent Applications and Registrations

Patent applications and USPTO patent grants for Weeratunga; Gamini.The latest application filed is for "processes for the preparation of veliparib and intermediates thereof".

Company Profile

10.24.35

Weeratunga; Gamini - Ancaster CA
Weeratunga; Gamini - Brantford CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Process for the preparation of acalabrutinib Grant 10,800,787 - Bodhuri , et al. October 13, 2	2020-10-13
Processes for the Preparation of Veliparib and Intermediates Thereof App 20200172514 - Bodhuri; Prabhudas ; et al.	2020-06-04
Processes for the Preparation of Acalabrutinib and Intermediates Thereof App 20200048264 - Bodhuri; Prabhudas ; et al.	2020-02-13
Processes for the preparation of Veliparib and intermediates thereof Grant 10,556,887 - Bodhuri , et al. Feb	2020-02-11
Processes for the Preparation of Dasotraline and Intermediates Thereof App 20190390235 - Souza; Fabio E. S. ; et al.	2019-12-26
Processes for the preparation of apalutamide and intermediates thereof Grant 10,513,504 - Bodhuri , et al. Dec	2019-12-24
Processes for the Preparation of 3-(4-Halobutyl)-5-Cyanoindole App 20190330150 - Weeratunga; Gamini ; et al.	2019-10-31
Processes for the Preparation of Apalutamide and Intermediates Thereof App 20190276424 - Bodhuri; Prabhudas ; et al.	2019-09-12
Processes for the preparation of lesinurad and intermediates thereof Grant 10,351,537 - Bodhuri , et al. July 16, 2	2019-07-16
Processes for the Preparation of Dasotraline and Intermediates Thereof App 20190194122 - Bodhuri; Prabhudas ; et al.	2019-06-27
Processes for the Preparation of Veliparib and Intermediates Thereof App 20190119257 - Bodhuri; Prabhudas ; et al.	2019-04-25
Processes for the Preparation of Lesinurad and Intermediates Thereof App 20180258057 - Bodhuri; Prabhudas ; et al.	2018-09-13
Processes for the preparation of Tasimelteon and intermediates thereof Grant 9,944,616 - Zhao , et al. April 17, 2	2018-04-17
Processes for the Preparation of Tasimelteon and Intermediates Thereof App 20170355688 - Zhao; Yajun ; et al.	2017-12-14
Processes for the Preparation of Rotigotine and Intermediates Thereof App 20170305877 - Johansen; Michael B. ; et al.	2017-10-26
Processes for the preparation of 3-alkyl indoles Grant 9,533,949 - Stewart , et al. January 3, 2	2017-01-03
Forms of vilazodone and processes for the preparation thereof Grant 9,382,233 - Weeratunga , et al. July 5, 2	2016-07-05
Solid forms of nilotinib hydrochloride Grant 9,376,419 - Datta , et al. June 28, 2	2016-06-28
Solid Forms Of Nilotinib Hydrochloride App 20150274699 - Datta; Probal Kanti ; et al.	2015-10-01
Processes For The Preparation Of 3-alkyl Indoles App 20150252000 - Stewart; Craig ; et al.	2015-09-10
Polymorphic forms of Lapatinib ditosylate and processes for their preparation Grant 8,993,579 - Zetina-Rocha , et al. March 31, 2	2015-03-31
Process for the preparation of lapatinib and its ditosylate salt Grant 8,952,154 - Raheem , et al. February 10, 2	2015-02-10
Polymorphic forms of Warfarin potassium and preparations thereof Grant 8,765,976 - Bodhuri , et al. July 1, 2	2014-07-01
Process For The Preparation Of Lapatinib And Its Ditosylate Salt App 20140018535 - Raheem; Mohammed Abdul ; et al.	2014-01-16
Polymorphic Forms Of Warfarin Potassium And Preparations Thereof App 20130143957 - Bodhuri; Prabhudas ; et al.	2013-06-06
Polymorphic Forms Of Lapatinib Ditosylate And Processes For Their Preparation App 20130123497 - Zetina-Rocha; Carlos ; et al.	2013-05-16
Processes for the preparation of rivaroxaban and intermediates thereof Grant 8,435,989 - Bodhuri , et al. May 7, 2	2013-05-07
Processes For The Preparation Of Rivaroxaban And Intermediates Thereof App 20130072680 - Bodhuri; Prabhudas ; et al.	2013-03-21
Processes for the Purification of Lubiprostone App 20120309990 - Weeratunga; Gamini ; et al.	2012-12-06
Processes for the preparation of rivaroxaban and intermediates thereof Grant 8,309,547 - Bodhuri , et al. November 13, 2	2012-11-13
Amorphous form of an L-arginine salt of perindopril and processes for preparation thereof Grant 8,101,646 - Weeratunga , et al. January 24, 2	2012-01-24
Processes for the preparation of rivaroxaban and intermediates thereof Grant 8,101,609 - Bodhuri , et al. January 24, 2	2012-01-24
Preparation Of Oseltamivir Phosphate (tamiflu.rtm.) And Intermediates Starting From D-glucose Or D-xylose App 20110040120 - RADATUS; Bruno Konrad ; et al.	2011-02-17
Processes For The Preparation Of Rivaroxaban And Intermediates Thereof App 20110034465 - BODHURI; Prabhudas ; et al.	2011-02-10
Processes For The Preparation Of Rivaroxaban And Intermediates Thereof App 20100273790 - BODHURI; Prabhudas ; et al.	2010-10-28
Processes For The Preparation Of Rivaroxaban And Intermediates Thereof App 20100273798 - BODHURI; Prabhudas ; et al.	2010-10-28
Processes for the preparation of rivaroxaban and intermediates thereof Grant 7,816,355 - Bodhuri , et al. October 19, 2	2010-10-19
Polymorphic Form Of 5 Chloro N {[(5s) 2 Oxo 3 [4 (3 Oxomorpholin 4 Yl)phenyl]oxa-zolidin 5 Yl]-methyl}thiophene 2 Carboxamide App 20100168111 - Bodhuri; Prabhudas ; et al.	2010-07-01
Amorphous Form Of An L-arginine Salt Of Perindopril And Processes For Preparation Thereof App 20100056802 - WEERATUNGA; Gamini ; et al.	2010-03-04
Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers Grant 7,485,754 - Wang , et al. February 3, 2	2009-02-03
Process for the preparation of zonisamide and the intermediates thereof Grant 7,375,233 - Weeratunga , et al. May 20, 2	2008-05-20
Process for the preparation of Zonisamide and the intermediates thereof App 20080033181 - Weeratunga; Gamini ; et al.	2008-02-07
Preparation of oseltamivir phosphate (Tamiflu) and intermediates starting from D-glucose or D-xylose App 20080009639 - Radatus; Bruno Konrad ; et al.	2008-01-10
Process for the preparation of zonisamide and the intermediates thereof App 20070142644 - Weeratunga; Gamini ; et al.	2007-06-21
Efficient method for preparing 3-aryloxy-3-arylpropylamines and their optical stereoisomers App 20070010678 - Wang; Zhi-Xian ; et al.	2007-01-11
Process for the preparation of midodrine, pharmaceutically acceptable salts thereof and intermediates App 20060264671 - Weeratunga; Gamini ; et al.	2006-11-23
Process for the preparation of tetrahydrothieno[3,2-c] pyridine derivatives Grant 7,060,831 - Smyj , et al. June 13, 2	2006-06-13
Process for the preparation of polypeptide 1 Grant 7,049,399 - Bejan , et al. May 23, 2	2006-05-23
Resolution of racemates of methyl alpha-5-[4,5,6,7-tetrahydro[3,2-C]thieno- pyridyl]-(2-chlorophenyl) acetate App 20050176960 - Murthy, K. S. Keshava ; et al.	2005-08-11
Process for the preparation of tetrahydrothieno [3,2-C] pyridine derivatives App 20050137401 - Smyj, Robert P. ; et al.	2005-06-23
Process for the preparation of polypeptide 1 App 20040091956 - Bejan, Elena ; et al.	2004-05-13
Process For Producing Simvastatin App 20010053859 - MURTHY, K. S. KESHAVA ; et al.	2001-12-20
Commercial process for the manufacture of fluconazole and intermediates useful in the manufacture thereof Grant 5,872,258 - Clive , et al. February 16, 1	1999-02-16

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.